Neurotech Solutions

Company Overview

Snapshot

Founded in March 2008, Neurotech Solutions operates with 11–50 employees. The company has secured $3.55M in total capital across 3 funding rounds from 3 investors. In March 2018, Neurotech Solutions received a significant investment from Guangzhou Sino-Israel Biotech Investment Fund (GIBF) to support its growth in the ADHD screening and diagnosis market in China.

Business overview

Neurotech Solutions is a digital health company dedicated to eliminating undiagnosed ADHD and helping individuals with ADHD lead better lives. Its core technology is a cloud-based, AI-driven online test designed to resemble a game. This technology is implemented in MOXO d-CPT, a clinical decision-support tool for ADHD diagnosis, and AXON-School, an educational product for K-12 children that identifies attentional difficulties and suggests personalized learning strategies. The company serves healthcare providers, educational institutions, and consumers in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Medical Decision Support.

Strategic signal

In March 2018, Neurotech Solutions secured $3.5 million to accelerate the growth of its ADHD screening and diagnosis business within the Chinese market. This strategic investment highlights the company's focus on international expansion and the increasing demand for AI-driven diagnostic tools in major global markets, signaling strong commercial validation and potential for significant market penetration.

Company Intelligence Q&A

What is Neurotech Solutions' primary focus?

Neurotech Solutions is a digital health company focused on eliminating undiagnosed ADHD and helping individuals with ADHD fulfill their potential.

What is MOXO d-CPT?

MOXO d-CPT is a clinical product developed by Neurotech Solutions, utilizing its core AI-driven technology as a decision-support tool for the diagnosis of ADHD. It provides objective, standardized, comparative results about a patient's attentional difficulties.

What is AXON-School?

AXON-School is an educational product from Neurotech Solutions, intended for K-12 children, that objectively highlights children with attentional difficulties and suggests educational strategies for personalized learning.

When did Neurotech Solutions expand into China?

In March 2018, Neurotech Solutions secured $3.5 million from Guangzhou Sino-Israel Biotech Investment Fund (GIBF) to fuel the aggressive growth of its ADHD screening and diagnosis business in China. The company also opened a subsidiary in Guangzhou, China, in 2021.

Has Neurotech Solutions received any non-equity funding?

In August 2019, Neurotech Solutions secured a grant from EU Horizon 2020 for the MOXO-Mobile Phase-1 Project, focusing on a mobile device for ADHD diagnosis and support.